AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33251662 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst stimulation (BST)
Number of subjects: 19
Study 33251662 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study 34619136 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial-eligible recipients
Number of subjects: 4610
Study 34619136 — intervention group
Group type: COMPARATOR
Intervention: Trial-ineligible recipients
Number of subjects: 4610
Study 34619136 — intervention group
Group type: COMPARATOR
Intervention: Trial-ineligible recipients meeting one ineligibility criterion
Number of subjects: 4610
Study 34619136 — intervention group
Group type: COMPARATOR
Intervention: Trial-ineligible recipients meeting two ineligibility criteria
Number of subjects: 4610
Study 34619136 — intervention group
Group type: COMPARATOR
Intervention: Trial-ineligible recipients meeting three or more ineligibility criteria
Number of subjects: 4610
Study 34171389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose + oral iron bisglycinate (60 mg for 45 days)
Number of subjects: 158
Study 34171389 — intervention group
Group type: COMPARATOR
Intervention: Intravenous iron sucrose only
Number of subjects: 158
Study 34171389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose + oral iron bisglycinate
Number of subjects: 158
Study 35922216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinepazide maleate injection
Number of subjects: 809
Study 35922216 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 809
Study 33280348 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon exercise program
Number of subjects: 47
Study 33280348 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning exercise program
Number of subjects: 47
Study 33280348 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 47
Study 35584353 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise (16 sessions over 10-18 weeks, aerobic and resistance training at moderate-to-vigorous intensity)
Number of subjects: 760
Study 35584353 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise
Number of subjects: 760
Study 33277646 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance
Number of subjects: 4636
Study 33277646 — intervention group
Group type: COMPARATOR
Intervention: Anatomical landmarks (AL)
Number of subjects: 4636
Study 34462864 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 4 weeks + topical corticosteroids (TCS)
Number of subjects: 367
Study 34462864 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 100 or 200 mg every 2 weeks + TCS
Number of subjects: 367
Study 34462864 — intervention group
Group type: COMPARATOR
Intervention: Placebo + TCS
Number of subjects: 367
Study 33228511 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor 1 g/day
Number of subjects: 40
Study 33228511 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor 2 g/day
Number of subjects: 40
Study 33228511 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 36000257 — intervention group
Group type: EXPERIMENTAL
Intervention: Durable polymer drug-eluting stents (DP-DES)
Number of subjects: 1140
Study 36000257 — intervention group
Group type: COMPARATOR
Intervention: Biodegradable polymer drug-eluting stents (BP-DES)
Number of subjects: 1140
Study 33544707 — intervention group
Group type: EXPERIMENTAL
Intervention: T1-weighted MRI
Number of subjects: 45
Study 33544707 — intervention group
Group type: COMPARATOR
Intervention: T2-weighted MRI
Number of subjects: 45
Study 33544707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-rater reliability
Number of subjects: 45
Study 33769858 — intervention group
Group type: EXPERIMENTAL
Intervention: Eluxadoline
Number of subjects: 346
Study 34748450 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Hamstring Exercise (NHE) - 4 sets of 10 repetitions
Number of subjects: 24
Study 34748450 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no NHE session
Number of subjects: 24
Study 34696674 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (200 mg/day)
Number of subjects: 60
Study 34696674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33524545 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant ADT for 6 months starting 4 months before prostate radiation therapy
Number of subjects: 393
Study 33524545 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant ADT for 6 months starting simultaneously with prostate radiation therapy
Number of subjects: 393
Study 32166681 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 kVp, 270 mgI/mL
Number of subjects: 121
Study 32166681 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp, 270 mgI/mL
Number of subjects: 121
Study 32166681 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp, 320 mgI/mL
Number of subjects: 121
Study 32166681 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp, 400 mgI/mL
Number of subjects: 121
Study 35905806 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 30
Study 35905806 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study 33618229 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred information intervention
Number of subjects: 13
Study 32794481 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyriax manipulation with 10 min pre‐manipulative massage
Number of subjects: 40
Study 32794481 — intervention group
Group type: COMPARATOR
Intervention: Traditional physical therapy (cervical isometrics and targeted muscle stretchings)
Number of subjects: 40
Study 35266184 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacitive resistive monopolar radiofrequency (CRMRF) treatment at 448 kHz
Number of subjects: 81
Study 35266184 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment with the same physiotherapeutic techniques
Number of subjects: 81
Study 32649637 — intervention group
Group type: EXPERIMENTAL
Intervention: Low SBPV (CoV <5%)
Number of subjects: 0
Study 32649637 — intervention group
Group type: EXPERIMENTAL
Intervention: High SBPV (CoV >10%)
Number of subjects: 0
Study 36054266 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-coated balloon (SCB)
Number of subjects: 1325
Study 36054266 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stent (DES)
Number of subjects: 1325
Study 33827283 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing-based leg exercises program (ExBr) for 12 weeks, 15 minutes per session, three times a week.
Number of subjects: 86
Study 33827283 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 86
Study 35114129 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation chemotherapy
Number of subjects: 0
Study 32910094 — intervention group
Group type: EXPERIMENTAL
Intervention: RT‐HIIT
Number of subjects: 240
Study 32910094 — intervention group
Group type: EXPERIMENTAL
Intervention: AT‐HIIT
Number of subjects: 240
Study 32910094 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 240
Study 36405096 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-moderate salt consumption
Number of subjects: 121
Study 36405096 — intervention group
Group type: EXPERIMENTAL
Intervention: High salt consumption
Number of subjects: 121
Study 36405096 — intervention group
Group type: COMPARATOR
Intervention: Non-consumers of salt
Number of subjects: 121
Study 34218053 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.8 mg daily
Number of subjects: 97
Study 34218053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 34111610 — intervention group
Group type: EXPERIMENTAL
Intervention: AMEn concentration of 2,680 kcal/kg
Number of subjects: 72
Study 34111610 — intervention group
Group type: EXPERIMENTAL
Intervention: AMEn concentration of 2,780 kcal/kg
Number of subjects: 72
Study 34111610 — intervention group
Group type: EXPERIMENTAL
Intervention: DLys level of 0.68%
Number of subjects: 72
Study 34111610 — intervention group
Group type: EXPERIMENTAL
Intervention: DLys level of 0.80%
Number of subjects: 72
Study 32975383 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS) programs
Number of subjects: 41
Study 32975383 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic procedures
Number of subjects: 41
Study 32975383 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary catheter removal timing in colon surgery
Number of subjects: 41
Study 32975383 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary catheter removal timing in rectal surgery
Number of subjects: 41
Study 36286741 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifiform 2 capsules 2 times a day for 2 weeks, along with mebeverin 200 mg 2 times a day or trimebutin 200 mg 3 times a day for 4 weeks, rifaximin 400 mg 3 times a day or nifuroxazide 400 mg 2 times a day for 1 week, and a drug that normalizes feces consistency (dioctahedral smectite or macrogol 4000)
Number of subjects: 62
Study 36286741 — intervention group
Group type: COMPARATOR
Intervention: Control group received similar therapy without Bifiform
Number of subjects: 62
Study 36271257 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraventricular KCl injection
Number of subjects: 158
Study 36271257 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventricular septal KCl administration
Number of subjects: 158
Study 32778391 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 180
Study 32778391 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 180
Study 32778391 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study 35852527 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (n = 185), given orally twice daily at a dose of 25 mg, 37.5 mg, or 50 mg for 20 weeks.
Number of subjects: 276
Study 35852527 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 91), given orally twice daily for 20 weeks.
Number of subjects: 276
Study 35852527 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (n = 185)
Number of subjects: 276
Study 35852527 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 91)
Number of subjects: 276
Study 34892637 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz-tACS
Number of subjects: 44
Study 34892637 — intervention group
Group type: COMPARATOR
Intervention: Sham-stimulation
Number of subjects: 44
Study 35938324 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro‐needle knife therapy
Number of subjects: 200
Study 35938324 — intervention group
Group type: COMPARATOR
Intervention: Betahistine mesilate tablets (6 mg, three times a day for 14 days)
Number of subjects: 200
Study 32055994 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 66
Study 32055994 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 66
Study 32103640 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-day educational programme
Number of subjects: 338
Study 32103640 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 338
Study 33547036 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher fraction of fetal haemoglobin (HbF) (%)
Number of subjects: 452
Study 33547036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest quartile of HbF (%)
Number of subjects: 452
Study 33547036 — intervention group
Group type: EXPERIMENTAL
Intervention: HbF (%) in the full model during the first week
Number of subjects: 452
Study 32862856 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax with azacitidine
Number of subjects: 0
Study 32862856 — intervention group
Group type: COMPARATOR
Intervention: Azacitidine alone
Number of subjects: 0
Study 33615815 — intervention group
Group type: EXPERIMENTAL
Intervention: DCBE eye drops for 4 weeks
Number of subjects: 53
Study 33615815 — intervention group
Group type: COMPARATOR
Intervention: 0.3% SH eye drops for 4 weeks
Number of subjects: 53
Study 32127653 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine 1/10,000
Number of subjects: 210
Study 32127653 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine 1/100,000
Number of subjects: 210
Study 32127653 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 210
Study 33755917 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy
Number of subjects: 216
Study 35561151 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ultramicrosize griseofulvin (Group A)
Number of subjects: 120
Study 35561151 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine (Group B)
Number of subjects: 120
Study 33347417 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrigid registration model after transfer learning (TL)
Number of subjects: 200
Study 33347417 — intervention group
Group type: COMPARATOR
Intervention: Nonrigid registration model without transfer learning (TL)
Number of subjects: 200
Study 33347417 — intervention group
Group type: COMPARATOR
Intervention: Traditional intensity-based methods
Number of subjects: 200
Study 34156180 — intervention group
Group type: EXPERIMENTAL
Intervention: WB‐HIIT (N=25)
Number of subjects: 50
Study 34156180 — intervention group
Group type: COMPARATOR
Intervention: Control (CON, N=25)
Number of subjects: 50
Study 33740751 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIKES protocol (user embracement group)
Number of subjects: 100
Study 33740751 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection with triamcinolone hexacetonide (40 mg)
Number of subjects: 100
Study 36356613 — intervention group
Group type: EXPERIMENTAL
Intervention: Setmelanotide (up to 3.0 mg subcutaneous once per day for 14 weeks)
Number of subjects: 38
Study 36356613 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once per day for 14 weeks)
Number of subjects: 38
Study 33906801 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel and ADT
Number of subjects: 773
Study 33906801 — intervention group
Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 773
Study 32319685 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative e-mail communication
Number of subjects: 6788
Study 32319685 — intervention group
Group type: EXPERIMENTAL
Intervention: Control e-mail plus phone call
Number of subjects: 6788
Study 32319685 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative e-mail plus phone call
Number of subjects: 6788
Study 32319685 — intervention group
Group type: COMPARATOR
Intervention: Control e-mail
Number of subjects: 6788
Study 36470216 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard service plus the 'Motivate Me' and 'My Activity Programme' apps
Number of subjects: 50
Study 36470216 — intervention group
Group type: COMPARATOR
Intervention: Standard service with a smartphone for outcome measurement only (Control)
Number of subjects: 50
Study 33393218 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal closure of the vaginal cuff before colpotomy
Number of subjects: 0
Study 33393218 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach to closing the vaginal cuff
Number of subjects: 0
Study 33960840 — intervention group
Group type: COMPARATOR
Intervention: Commercially available balloon expander
Number of subjects: 20
Study 33960840 — intervention group
Group type: EXPERIMENTAL
Intervention: Original balloon dilator (created with two middle fingers of a #8 powder‐free surgical glove tied to a nondisposable 11 mm trocar and filled with 600 mL of saline)
Number of subjects: 20
Study 33960840 — intervention group
Group type: EXPERIMENTAL
Intervention: Original balloon dilator
Number of subjects: 20
Study 33176277 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical posture correction with lumbar stabilization exercises (group A)
Number of subjects: 50
Study 33176277 — intervention group
Group type: COMPARATOR
Intervention: Lumbar stabilization exercises only (group B)
Number of subjects: 50
Study 35229714 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention communities
Number of subjects: 5114
Study 35229714 — intervention group
Group type: COMPARATOR
Intervention: Control communities
Number of subjects: 5114
Study 33225989 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (2000 mg daily in the form of two 'Fish Oil, Ultra Omega-3' capsules)
Number of subjects: 176
Study 33225989 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 identical placebo capsules daily)
Number of subjects: 176
Study 35562246 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided subclavian vein catheterization
Number of subjects: 85
Study 35562246 — intervention group
Group type: COMPARATOR
Intervention: Landmark method for subclavian vein catheterization
Number of subjects: 85
Study 35562246 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents and attending physicians
Number of subjects: 85
Study 33310908 — intervention group
Group type: EXPERIMENTAL
Intervention: CDF program participants (N = 335)
Number of subjects: 902
Study 33310908 — intervention group
Group type: COMPARATOR
Intervention: CDF nonparticipants (N = 211)
Number of subjects: 902
Study 34405486 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 33
Study 34405486 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential Current (IFC)
Number of subjects: 33
Study 34405486 — intervention group
Group type: COMPARATOR
Intervention: Stretching, strengthening, and stabilization exercises (all groups)
Number of subjects: 33
Study 32875512 — intervention group
Group type: EXPERIMENTAL
Intervention: Gout patients
Number of subjects: 163
Study 32875512 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 163
Study 32355161 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted magnesium concentration
Number of subjects: 25509
Study 32355161 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted β-carotene concentration
Number of subjects: 25509
Study 32355161 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted vitamin B12 concentration
Number of subjects: 25509
Study 32355161 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted vitamin E concentration
Number of subjects: 25509
Study 35300671 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist first assessment
Number of subjects: 69
Study 35300671 — intervention group
Group type: COMPARATOR
Intervention: Physician first assessment
Number of subjects: 69
Study 35300671 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 69
Study 35300671 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapist vs Physician
Number of subjects: 69
Study 34207545 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz, 20 sessions over 4 weeks)
Number of subjects: 120
Study 34207545 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 120
Study 35996760 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia VR-based training with peer support (3-month e-book modules, VR activities, 1-hour monthly peer support meetings)
Number of subjects: 124
Study 35996760 — intervention group
Group type: COMPARATOR
Intervention: Non-VR control group (3-month e-book modules, 1-hour monthly regular staff meetings)
Number of subjects: 124
Study 33288357 — intervention group
Group type: EXPERIMENTAL
Intervention: Damon self-ligating appliance
Number of subjects: 37
Study 33288357 — intervention group
Group type: COMPARATOR
Intervention: MARPE
Number of subjects: 37
Study 32402553 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 344
Study 32402553 — intervention group
Group type: COMPARATOR
Intervention: SLT
Number of subjects: 344
Study 35498786 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly motivational interviews on smoking reduction, 8-week nicotine replacement therapy, referral to smoking cessation service
Number of subjects: 210
Study 35498786 — intervention group
Group type: COMPARATOR
Intervention: Simple verbal advice on smoking cessation
Number of subjects: 210
Study 32792555 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval water-based exercise (WHIIE)
Number of subjects: 11
Study 32792555 — intervention group
Group type: COMPARATOR
Intervention: High-intensity interval land bike ergonomic exercise (LBEHIIE)
Number of subjects: 11
Study 35384931 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT)
Number of subjects: 148
Study 35384931 — intervention group
Group type: COMPARATOR
Intervention: CORE-MT
Number of subjects: 148
Study 33744781 — intervention group
Group type: EXPERIMENTAL
Intervention: Brigatinib
Number of subjects: 262
Study 33744781 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 262
Study 34544010 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based nursing process educational program (online interactive animation and standardized patient simulation)
Number of subjects: 107
Study 34544010 — intervention group
Group type: COMPARATOR
Intervention: Case-study (control group)
Number of subjects: 107
Study 34544010 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based nursing process educational program
Number of subjects: 107
Study 33197610 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA)
Number of subjects: 21
Study 33069608 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-guided exercises using the ReHand tablet application
Number of subjects: 74
Study 33069608 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program prescribed on paper
Number of subjects: 74
Study 36223848 — intervention group
Group type: EXPERIMENTAL
Intervention: tezepelumab plus subcutaneous cat SCIT
Number of subjects: 121
Study 33486593 — intervention group
Group type: EXPERIMENTAL
Intervention: One-way self-expanding rod (OWSER) unilateral construct for non-neuromuscular curves
Number of subjects: 20
Study 33486593 — intervention group
Group type: EXPERIMENTAL
Intervention: One-way self-expanding rod (OWSER) bilateral construct for neuromuscular scoliosis
Number of subjects: 20
Study 35212297 — intervention group
Group type: EXPERIMENTAL
Intervention: Open radical hysterectomy (ORH)
Number of subjects: 116
Study 35212297 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive radical hysterectomy (MIRH) using vaginal colpotomy (VC)
Number of subjects: 116